STOCK MARKET BSE NSE

Need to change Covaxin composition not felt yet due to vaccine's good efficacy against mutant variants: Government

There are four mutations of the COVID-19 virus in India at present -- two UK variants and one South African and Brazilian variant each, Minister of State for Health Ashwini Choubey said.

Published: 20th March 2021 08:15 AM  |   Last Updated: 20th March 2021 08:15 AM   |  A+A-

A health official shows Covaxin dose.

A health official shows Covaxin dose. (File Photo | Shekhar Yadav, EPS)

By PTI

NEW DELHI: The need to change the composition of Covaxin has not been felt yet in view of good efficacy of the vaccine against mutant variants, the government told Lok Sabha Friday.

There are four mutations of the COVID-19 virus in India at present -- two UK variants and one South African and Brazilian variant each, Minister of State for Health Ashwini Choubey said.

Providing details of the efficacy rate of Covaxin and Covishield vaccines against each of the mutations, he said there was no significant difference noted in the efficacy of Bharat Biotech's Covaxin against the UK and the Brazil strains.

However, analysis of Covaxin's efficacy against South African strain is ongoing, he said.

As for the Oxford-AstraZeneca COVID-19 vaccine Covishield, it has shown 74.6 per cent efficacy against the UK strain and has been shown to be effective against the Brazil strain.

However, its efficacy against the South Africa strain is just 10 per cent, the minister stated.

Continuous monitoring of evolution of mutations is being done by the Indian SARS- CoV-2 Genomics Surveillance Consortium (INSACOG), he said.

Besides, National Institute of Virology (NIV) is continuously engaged in virus isolation of different SARS-CoV-2 strains for further research.

Strains from South Africa and Brazil have been detected in travellers coming to India from these countries.

In order to curtail spread of these variants in India the government issued revised guidelines for international arrivals on February 17.

As per the guidelines, screening of passengers coming from South Africa, Brazil and the UAE has been made very stringent to prevent spread of infection due to variants, Choubey said.

On whether the government proposes to bring about changes in the existing vaccines available in the country to check the further spread of these two mutant strains, he said Oxford-AstraZeneca have initiated tweaking of the vaccine to make it efficacious against the mutant strains particularly the South African variant.

"The need to change composition of Covaxin has not been felt yet in view of good efficacy of the vaccine against variants," he said in the written reply.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp